These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 12086987)

  • 1. NO- and haem-independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle.
    Stasch JP; Schmidt P; Alonso-Alija C; Apeler H; Dembowsky K; Haerter M; Heil M; Minuth T; Perzborn E; Pleiss U; Schramm M; Schroeder W; Schröder H; Stahl E; Steinke W; Wunder F
    Br J Pharmacol; 2002 Jul; 136(5):773-83. PubMed ID: 12086987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct molecular requirements for activation or stabilization of soluble guanylyl cyclase upon haem oxidation-induced degradation.
    Hoffmann LS; Schmidt PM; Keim Y; Schaefer S; Schmidt HH; Stasch JP
    Br J Pharmacol; 2009 Jul; 157(5):781-95. PubMed ID: 19466990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide-independent stimulation of soluble guanylate cyclase with BAY 41-2272 in cardiovascular disease.
    Boerrigter G; Burnett JC
    Cardiovasc Drug Rev; 2007; 25(1):30-45. PubMed ID: 17445086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of haem-oxidized soluble guanylyl cyclase with BAY 60-2770 in human platelets lead to overstimulation of the cyclic GMP signaling pathway.
    Mendes-Silverio CB; Leiria LO; Morganti RP; Anhê GF; Marcondes S; Mónica FZ; De Nucci G; Antunes E
    PLoS One; 2012; 7(11):e47223. PubMed ID: 23144808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NO-independent, haem-dependent soluble guanylate cyclase stimulators.
    Stasch JP; Hobbs AJ
    Handb Exp Pharmacol; 2009; (191):277-308. PubMed ID: 19089334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fibrate gemfibrozil is a NO- and haem-independent activator of soluble guanylyl cyclase: in vitro studies.
    Sharina IG; Sobolevsky M; Papakyriakou A; Rukoyatkina N; Spyroulias GA; Gambaryan S; Martin E
    Br J Pharmacol; 2015 May; 172(9):2316-29. PubMed ID: 25536881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced vascular responses to soluble guanylyl cyclase but increased sensitivity to sildenafil in female rats with type 2 diabetes.
    Goulopoulou S; Hannan JL; Matsumoto T; Ogbi S; Ergul A; Webb RC
    Am J Physiol Heart Circ Physiol; 2015 Jul; 309(2):H297-304. PubMed ID: 25957216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of nitric oxide independent activation of soluble guanylyl cyclase.
    Schmidt P; Schramm M; Schröder H; Stasch JP
    Eur J Pharmacol; 2003 May; 468(3):167-74. PubMed ID: 12754054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of the nitric oxide receptor, soluble guanylyl cyclase, in cerebellar cells.
    Bellamy TC; Garthwaite J
    Br J Pharmacol; 2002 May; 136(1):95-103. PubMed ID: 11976273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NO-independent stimulation or activation of soluble guanylyl cyclase during early reperfusion limits infarct size.
    Bice JS; Keim Y; Stasch JP; Baxter GF
    Cardiovasc Res; 2014 Feb; 101(2):220-8. PubMed ID: 24259501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acrylamide analog as a novel nitric oxide-independent soluble guanylyl cyclase activator.
    Nakane M; Kolasa T; Chang R; Miller LN; Moreland RB; Brioni JD
    J Pharmacol Sci; 2006 Oct; 102(2):231-8. PubMed ID: 17050951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescence dequenching makes haem-free soluble guanylate cyclase detectable in living cells.
    Hoffmann LS; Schmidt PM; Keim Y; Hoffmann C; Schmidt HH; Stasch JP
    PLoS One; 2011; 6(8):e23596. PubMed ID: 21858179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiplatelet properties of a novel, non-NO-based soluble guanylate cyclase activator, BAY 41-2272.
    Hobbs AJ; Moncada S
    Vascul Pharmacol; 2003 Oct; 40(3):149-54. PubMed ID: 13678646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NO- and haem-independent soluble guanylate cyclase activators.
    Schmidt HH; Schmidt PM; Stasch JP
    Handb Exp Pharmacol; 2009; (191):309-39. PubMed ID: 19089335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of nitroglycerin/L-cysteine on soluble guanylate cyclase: evidence for an activation/inactivation equilibrium controlled by nitric oxide binding and haem oxidation.
    Gorren AC; Russwurm M; Kollau A; Koesling D; Schmidt K; Mayer B
    Biochem J; 2005 Sep; 390(Pt 2):625-31. PubMed ID: 15907191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress impairs vasorelaxation induced by the soluble guanylyl cyclase activator BAY 41-2272 in spontaneously hypertensive rats.
    Priviero FB; Zemse SM; Teixeira CE; Webb RC
    Am J Hypertens; 2009 May; 22(5):493-9. PubMed ID: 19247264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preconditioning with soluble guanylate cyclase activation prevents postischemic inflammation and reduces nitrate tolerance in heme oxygenase-1 knockout mice.
    Wang WZ; Jones AW; Wang M; Durante W; Korthuis RJ
    Am J Physiol Heart Circ Physiol; 2013 Aug; 305(4):H521-32. PubMed ID: 23771693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A functional domain of the alpha1 subunit of soluble guanylyl cyclase is necessary for activation of the enzyme by nitric oxide and YC-1 but is not involved in heme binding.
    Koglin M; Behrends S
    J Biol Chem; 2003 Apr; 278(14):12590-7. PubMed ID: 12560334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular and pharmacological implications of haem-deficient NO-unresponsive soluble guanylate cyclase knock-in mice.
    Thoonen R; Cauwels A; Decaluwe K; Geschka S; Tainsh RE; Delanghe J; Hochepied T; De Cauwer L; Rogge E; Voet S; Sips P; Karas RH; Bloch KD; Vuylsteke M; Stasch JP; Van de Voorde J; Buys ES; Brouckaert P
    Nat Commun; 2015 Oct; 6():8482. PubMed ID: 26442659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of cinaciguat (BAY 58-2667) bound to Nostoc H-NOX domain reveals insights into heme-mimetic activation of the soluble guanylyl cyclase.
    Martin F; Baskaran P; Ma X; Dunten PW; Schaefer M; Stasch JP; Beuve A; van den Akker F
    J Biol Chem; 2010 Jul; 285(29):22651-7. PubMed ID: 20463019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.